{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:43:45Z","timestamp":1725497025665},"publisher-location":"Berlin, Heidelberg","reference-count":110,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540331766"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-3-540-33177-3_12","type":"book-chapter","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T01:57:51Z","timestamp":1196733471000},"page":"215-231","source":"Crossref","is-referenced-by-count":7,"title":["Endogenous Inhibitors of Angiogenesis"],"prefix":"10.1007","author":[{"given":"Malin","family":"Sund","sequence":"first","affiliation":[]},{"given":"Raghu","family":"Kalluri","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0002-9440(10)63210-5","volume":"164","author":"R. Abe","year":"2004","unstructured":"Abe R, Shimizu T, Yamagishi S, Shibaki A, Amano S, Inagaki Y, Watanabe H, Sugawara H, Nakamura H, Takeuchi M et al (2004) Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164:1225\u20131232","journal-title":"Am J Pathol"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1073\/pnas.0409844102","volume":"102","author":"M.E. Akerman","year":"2005","unstructured":"Akerman ME, Pilch J, Peters D, Ruoslahti E (2005) Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc Natl Acad Sci USA 102:2040\u20132045","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/104454904323145254","volume":"23","author":"A.R. Albig","year":"2004","unstructured":"Albig AR, Schiemann WP (2004) Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 23:367\u2013379","journal-title":"DNA Cell Biol"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/0008-5472.148.65.1","volume":"65","author":"A. Ambesi","year":"2005","unstructured":"Ambesi A, Klein RM, Pumiglia KM, McKeown-Longo PJ (2005) Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells. Cancer Res 65:148\u2013156","journal-title":"Cancer Res"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0945-053X(03)00005-2","volume":"22","author":"L.C. Armstrong","year":"2003","unstructured":"Armstrong LC, Bornstein P (2003) Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 22:63\u201371","journal-title":"Matrix Biol"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/mp.55.5.300","volume":"55","author":"E.A. Baker","year":"2002","unstructured":"Baker EA, Stephenson TJ, Reed MW, Brown NJ (2002) Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol Pathol 55:300\u2013304","journal-title":"Mol Pathol"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-2004-831051","volume":"30","author":"A. Bikfalvi","year":"2004","unstructured":"Bikfalvi A (2004) Platelet factor 4: an inhibitor of angiogenesis. Semin Thromb Hemost 30:379\u2013385","journal-title":"Semin Thromb Hemost"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1083\/jcb.200401150","volume":"166","author":"G Bix","year":"2004","unstructured":"Bix G, Fu J, Gonzalez EM, Macro L, Barker A, Campbell S, Zutter MM, Santoro SA, Kim JK, Hook M et al (2004) Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2betal integrin. J Cell Biol 166:97\u2013109","journal-title":"J Cell Biol"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S1471-4914(02)02362-6","volume":"8","author":"N. Bouck","year":"2002","unstructured":"Bouck N (2002) PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 8:330\u2013334","journal-title":"Trends Mol Med"},{"key":"12_CR10","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fasebj.13.15.2195","volume":"13","author":"R. Cao","year":"1999","unstructured":"Cao R, Farnebo J, Kurimoto M, Cao Y (1999) Interleukin-18 acts as an angiogenesis and tumor suppressor. Faseb J 13:2195\u20132202","journal-title":"Faseb J"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1073\/pnas.95.10.5579","volume":"95","author":"L. Claesson-Welsh","year":"1998","unstructured":"Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O\u2019Reilly M, Folkman J (1998) Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 95:5579\u20135583","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR12","first-page":"2520","volume":"60","author":"P.C. Colorado","year":"2000","unstructured":"Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK et al (2000) Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60:2520\u20132526","journal-title":"Cancer Res"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1677\/joe.0.1730219","volume":"173","author":"A.M. Corbacho","year":"2002","unstructured":"Corbacho AM, Martinez De La Escalera G, Clapp C (2002) Roles of prolactin and related members of the prolactin\/ growth hormone\/placental lactogen family in angiogenesis. J Endocrinol 173:219\u2013238","journal-title":"J Endocrinol"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.4049\/jimmunol.161.12.6845","volume":"161","author":"L.A. Cornelius","year":"1998","unstructured":"Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD (1998) Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 161:6845\u20136852","journal-title":"J Immunol"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","volume":"10","author":"D. Cosgrove","year":"1996","unstructured":"Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC (1996) Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev 10:2981\u20132992","journal-title":"Genes Dev"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1083\/jcb.147.5.1109","volume":"147","author":"M. Costell","year":"1999","unstructured":"Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109\u20131122","journal-title":"J Cell Biol"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1073\/pnas.87.17.6487","volume":"87","author":"F. Cozzolino","year":"1990","unstructured":"Cozzolino F, Torcia M, Aldinucci D, Ziehe M, Almerigogna F, Bani D, Stern DM (1990) Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 87:6487\u20136491","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1021\/jm00012a003","volume":"38","author":"M. Cushman","year":"1995","unstructured":"Cushman M, He HM, Katzenellenbogen JA, Lin CM, Hamel E (1995) Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J Med Chem 38:2041\u20132049","journal-title":"J Med Chem"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1073\/pnas.91.9.3964","volume":"91","author":"R.J. D\u2019Amato","year":"1994","unstructured":"D\u2019Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964\u20133968","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1073\/pnas.92.14.6374","volume":"92","author":"G. D\u2019Angelo","year":"1995","unstructured":"D\u2019Angelo G, Struman I, Martial J, Weiner RI (1995) Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374\u20136378","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1210\/me.13.5.692","volume":"13","author":"G. D\u2019Angelo","year":"1999","unstructured":"D\u2019Angelo G, Martini JF, Iiri T, Fantl WJ, Martial J, Weiner RI (1999) 16 K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol Endocrinol 13:692\u2013704","journal-title":"Mol Endocrinol"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"11721","DOI":"10.1074\/jbc.274.17.11721","volume":"274","author":"M. Dhanabal","year":"1999","unstructured":"Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, Sukhatme VP (1999a) Endostatin induces endothelial cell apoptosis. J Biol Chem 274:11721\u201311726","journal-title":"J Biol Chem"},{"key":"12_CR23","first-page":"189","volume":"59","author":"M. Dhanabal","year":"1999","unstructured":"Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M, Sukhatme VP (1999b) Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res 59:189\u2013197","journal-title":"Cancer Res"},{"key":"12_CR24","first-page":"808","volume":"58","author":"C.P. Dinney","year":"1998","unstructured":"Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ (1998) Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res 58:808\u2013814","journal-title":"Cancer Res"},{"key":"12_CR25","first-page":"1944","volume":"62","author":"J. Dixelius","year":"2002","unstructured":"Dixelius J, Cross M, Matsumoto T, Sasaki T, Timpl R, Claesson-Welsh L (2002) Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res 62:1944\u20131947","journal-title":"Cancer Res"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0002-9394(03)01422-3","volume":"137","author":"E.J. Duh","year":"2004","unstructured":"Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ (2004) Vitreous levels of pigment epitheliumderived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 137:668\u2013674","journal-title":"Am J Ophthalmol"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1073\/pnas.031444798","volume":"98","author":"L. Eklund","year":"2001","unstructured":"Eklund L, Piuhola J, Komulainen J, Sormunen R, Ongvarrasopone C, Fassler R, Muona A, lives M, Ruskoaho H, Takala TE, Pihlajaniemi T (2001) Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci USA 98:1194\u20131199","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/emboj\/19.6.1187","volume":"19","author":"U. Felbor","year":"2000","unstructured":"Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W (2000) Secreted cathepsin L generates endostatin from collagen XVIII. Embo J 19:1187\u20131194","journal-title":"Embo J"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1210\/endo-129-2-896","volume":"129","author":"N. Ferrara","year":"1991","unstructured":"Ferrara N, Clapp C, Weiner R (1991) The 16 K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896\u2013900","journal-title":"Endocrinology"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0945-053X(02)00010-0","volume":"21","author":"D. Ferrari","year":"2002","unstructured":"Ferrari Do, Outeiro-Bernstein MA, Nunes SS, Andrade AC, Alves TR, Legrand C, Morandi V (2002) A recombinant NH(2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Matrix Biol 21:311\u2013324","journal-title":"Matrix Biol"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1600-0463.2004.apm11207-0809.x","volume":"112","author":"J. Folkman","year":"2004","unstructured":"Folkman J (2004) Endogenous angiogenesis inhibitors. Apmis 112:496\u2013507","journal-title":"Apmis"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/00000658-198709000-00016","volume":"206","author":"J. Folkman","year":"1987","unstructured":"Folkman J, Ingber DE (1987) Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206:374\u2013383","journal-title":"Ann Surg"},{"key":"12_CR33","first-page":"161","volume-title":"Cancer medicine 6","author":"J. Folkman","year":"2003","unstructured":"Folkman J, Kalluri R (2003) Tumor angiogenesis. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC Jr, Gansler TS, Holland JF, Frei E III (eds) Cancer medicine 6. Delger, Hamilton, Canada, pp 161\u2013194"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/427787a","volume":"427","author":"J. Folkman","year":"2004","unstructured":"Folkman J, Kalluri R (2004) Cancer without disease. Nature 427:787","journal-title":"Nature"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/emboj\/21.7.1535","volume":"21","author":"N. Fukai","year":"2002","unstructured":"Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, Niemela M, lives M, Li E, Pihlajaniemi T, Olsen BR (2002) Lack of collagen XVIII\/endostatin results in eye abnormalities. Embo J 21:1535\u20131544","journal-title":"Embo J"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1538-7836.2004.00544.x","volume":"2","author":"J.H. Geiger","year":"2004","unstructured":"Geiger JH, Cnudde SE (2004) What the structure of angiostatin may tell us about its mechanism of action. J Thromb Haemost 2:23\u201334","journal-title":"J Thromb Haemost"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1074\/jbc.M409841200","volume":"280","author":"E.M. Gonzalez","year":"2005","unstructured":"Gonzalez EM, Reed CC, Bix G, Fu J, Zhang Y, Gopalakrishnan B, Greenspan DS, Iozzo RV (2005) BMP-1\/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 280:7080\u20137087","journal-title":"J Biol Chem"},{"key":"12_CR38","first-page":"6884","volume":"62","author":"M. Hagedorn","year":"2002","unstructured":"Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A (2002) Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Cancer Res 62:6884\u20136890","journal-title":"Cancer Res"},{"key":"12_CR39","first-page":"2075","volume":"150","author":"P.M. Hagg","year":"1997","unstructured":"Hagg PM, Hagg PO, Peltonen S, Autio-Harmainen H, Pihlajaniemi T (1997) Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol 150:2075\u20132086","journal-title":"Am J Pathol"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","volume":"3","author":"Y. Hamano","year":"2003","unstructured":"Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3:589\u2013601","journal-title":"Cancer Cell"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D. Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353\u2013364","journal-title":"Cell"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1093\/emboj\/20.11.2631","volume":"20","author":"T. Hawighorst","year":"2001","unstructured":"Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, Brown LF, Bornstein P, Detmar M (2001) Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. Embo J 20:2631\u20132640","journal-title":"Embo J"},{"key":"12_CR43","first-page":"2641","volume":"48","author":"R.K. Jain","year":"1988","unstructured":"Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48:2641\u20132658","journal-title":"Cancer Res"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/sj.onc.1205291","volume":"21","author":"Y. Jiang","year":"2002","unstructured":"Jiang Y, Goldberg ID, Shi YE (2002) Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21:2245\u20132252","journal-title":"Oncogene"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrc1094","volume":"3","author":"R. Kalluri","year":"2003","unstructured":"Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422\u2013433","journal-title":"Nat Rev Cancer"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","volume":"275","author":"G.D. Kamphaus","year":"2000","unstructured":"Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275:1209\u20131215","journal-title":"J Biol Chem"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1097-2765(01)00225-8","volume":"7","author":"S.A. Karumanchi","year":"2001","unstructured":"Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z et al (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7:811\u2013822","journal-title":"Mol Cell"},{"key":"12_CR48","first-page":"5410","volume":"60","author":"Y.M. Kim","year":"2000","unstructured":"Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST, Kwon YG (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 60:5410\u20135413","journal-title":"Cancer Res"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"27872","DOI":"10.1074\/jbc.M202771200","volume":"277","author":"Y.M. Kim","year":"2002","unstructured":"Kim YM, Hwang S, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR\/Flk-1. J Biol Chem 277:27872\u201327879","journal-title":"J Biol Chem"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0014-5793(81)81012-5","volume":"125","author":"K. Kuhn","year":"1981","unstructured":"Kuhn K, Wiedemann H, Timpl R, Risteli J, Dieringer H, Voss T, Glanville RW (1981) Macromolecular structure of basement membrane collagens. FEBS Lett 125:123\u2013128","journal-title":"FEBS Lett"},{"key":"12_CR51","first-page":"6723","volume":"60","author":"H. Larsson","year":"2000","unstructured":"Larsson H, Sjoblom T, Dixelius J, Ostman A, Ylinenjarvi K, Bjork I, Claesson-Welsh L (2000) Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res 60:6723\u20136729","journal-title":"Cancer Res"},{"key":"12_CR52","first-page":"3691","volume":"62","author":"T.M. LaVallee","year":"2002","unstructured":"LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62:3691\u20133697","journal-title":"Cancer Res"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1582-4934.2002.tb00307.x","volume":"6","author":"J. Lawler","year":"2002","unstructured":"Lawler J (2002) Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6:1\u201312","journal-title":"J Cell Mol Med"},{"key":"12_CR54","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0002-9440(10)63042-8","volume":"159","author":"J. Lawler","year":"2001","unstructured":"Lawler J, Miao WM, Duquette M, Bouck N, Bronson RT, Hynes RO (2001) Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am J Pathol 159:1949\u20131956","journal-title":"Am J Pathol"},{"key":"12_CR55","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1158\/0008-5472.CAN-05-0631","volume":"65","author":"S.H. Lee","year":"2005","unstructured":"Lee SH, Nishino M, Mazumdar T, Garcia GE, Galfione M, Lee FL, Lee CL, Liang A, Kim J, Feng L et al (2005) 16-kDa prolactin downregulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1\/IFN regulatory factor-1 pathway. Cancer Res 65:7984\u20137992","journal-title":"Cancer Res"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"28805","DOI":"10.1074\/jbc.273.44.28805","volume":"273","author":"T.H. Lee","year":"1998","unstructured":"Lee TH, Rhim T, Kim SS (1998) Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells. J Biol Chem 273:28805\u201328812","journal-title":"J Biol Chem"},{"key":"12_CR57","doi-asserted-by":"publisher","first-page":"22339","DOI":"10.1074\/jbc.M000519200","volume":"275","author":"D. Li","year":"2000","unstructured":"Li D, Clark CC, Myers JC (2000) Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem 275:22339\u201322347","journal-title":"J Biol Chem"},{"key":"12_CR58","first-page":"2517","volume":"42","author":"H.C. Lin","year":"2001","unstructured":"Lin HC, Chang JH, Jain S, Gabison EE, Kure T, Kato T, Fukai N, Azar DT (2001) Matrilysin cleavage of corneal collagen type XVIII NCI domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci 42:2517\u20132524","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12_CR59","first-page":"5551","volume":"58","author":"M.W. Lingen","year":"1998","unstructured":"Lingen MW, Polverini PJ, Bouck NP (1998) Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res 58:5551\u20135558","journal-title":"Cancer Res"},{"key":"12_CR60","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.167.9.5150","volume":"167","author":"Z. Ma","year":"2001","unstructured":"Ma Z, Qin H, Benveniste EN (2001) Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 167:5150\u20135159","journal-title":"J Immunol"},{"key":"12_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","volume":"3","author":"N.J. Mabjeesh","year":"2003","unstructured":"Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363\u2013375","journal-title":"Cancer Cell"},{"key":"12_CR62","doi-asserted-by":"publisher","first-page":"21340","DOI":"10.1074\/jbc.M001956200","volume":"275","author":"Y. Maeshima","year":"2000","unstructured":"Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R (2000a) Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275:21340\u201321348","journal-title":"J Biol Chem"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"23745","DOI":"10.1074\/jbc.C000186200","volume":"275","author":"Y. Maeshima","year":"2000","unstructured":"Maeshima Y, Colorado PC, Kalluri R (2000b) Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275:23745\u201323750","journal-title":"J Biol Chem"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1074\/jbc.M007764200","volume":"276","author":"Y. Maeshima","year":"2001","unstructured":"Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, Kharbanda S, Kalluri R (2001a) Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 276:15240\u201315248","journal-title":"J Biol Chem"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"31959","DOI":"10.1074\/jbc.M103024200","volume":"276","author":"Y. Maeshima","year":"2001","unstructured":"Maeshima Y, Yerramalla UL, Dhanabal M, Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M, Dickerson WM, Kalluri R (2001b) Extracellular matrixderived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem 276:31959\u201331968","journal-title":"J Biol Chem"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1126\/science.1065298","volume":"295","author":"Y. Maeshima","year":"2002","unstructured":"Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R (2002) Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295:140\u2013143","journal-title":"Science"},{"key":"12_CR67","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1158\/0008-5472.CAN-04-3536","volume":"65","author":"C. Magnon","year":"2005","unstructured":"Magnon C, Galaup A, Mullan B, Rouffiac V, Bouquet C, Bidart JM, Griscelli F, Opolon P, Perricaudet M (2005) Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Cancer Res 65:4353\u20134361","journal-title":"Cancer Res"},{"key":"12_CR68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.1688470","volume":"247","author":"T.E. Maione","year":"1990","unstructured":"Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77\u201379","journal-title":"Science"},{"issue":"[Suppll]","key":"12_CR69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1991.tb08124.x","volume":"79","author":"R.T. Mitsuyasu","year":"1991","unstructured":"Mitsuyasu RT (1991) Interferon alpha in the treatment of AIDS-related Kaposi\u2019s sarcoma. Br J Haematol 79[Suppll]:69\u201373","journal-title":"Br J Haematol"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1074\/jbc.M210445200","volume":"278","author":"M. Mongiat","year":"2003","unstructured":"Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278:4238\u20134249","journal-title":"J Biol Chem"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.gt.3302175","volume":"11","author":"M. Morini","year":"2004","unstructured":"Morini M, Albini A, Lorusso G, Moelling K, Lu B, Cilli M, Ferrini S, Noonan DM (2004) Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy. Gene Ther 11:284\u2013291","journal-title":"Gene Ther"},{"key":"12_CR72","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","volume":"96","author":"T.L. Moser","year":"1999","unstructured":"Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 96:2811\u20132816","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.1158\/0008-5472.CAN-05-1512","volume":"65","author":"R.E. Nisato","year":"2005","unstructured":"Nisato RE, Hosseini G, Sirrenberg C, Butler GS, Crabbe T, Docherty AJ, Wiesner M, Murphy G, Overall CM, Goodman SL, Pepper MS (2005) Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Cancer Res 65:9377\u20139387","journal-title":"Cancer Res"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1046\/j.1523-1747.2003.12643.x","volume":"121","author":"Y.H. Noh","year":"2003","unstructured":"Noh YH, Matsuda K, Hong YK, Kunstfeld R, Riccardi L, Koch M, Oura H, Dadras SS, Streit M, Detmar M (2003) An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo. J Invest Dermatol 121:1536\u20131543","journal-title":"J Invest Dermatol"},{"key":"12_CR75","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-04-2427","volume":"65","author":"P. Nyberg","year":"2005","unstructured":"Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65:3967\u20133979","journal-title":"Cancer Res"},{"key":"12_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"M.S. O\u2019Reilly","year":"1994","unstructured":"O\u2019Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315\u2013328","journal-title":"Cell"},{"key":"12_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"M.S. O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277\u2013285","journal-title":"Cell"},{"key":"12_CR78","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","volume":"285","author":"M.S. O\u2019Reilly","year":"1999","unstructured":"O\u2019Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J (1999) Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285:1926\u20131928","journal-title":"Science"},{"key":"12_CR79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/0008-5472.CAN-03-1941","volume":"64","author":"A.K. Olsson","year":"2004","unstructured":"Olsson AK, Larsson H, Dixelius J, Johansson I, Lee C, Oellig C, Bjork I, Claesson-Welsh L (2004) A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res 64:599\u2013605","journal-title":"Cancer Res"},{"key":"12_CR80","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jcb.240550403","volume":"55","author":"M.S. Pepper","year":"1994","unstructured":"Pepper MS, Vassalli JD, Wilks JW, Schweigerer L, Orci L, Montesano R (1994) Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 55:419\u2013434","journal-title":"J Cell Biochem"},{"key":"12_CR81","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1074\/jbc.275.11.8051","volume":"275","author":"E. Petitclerc","year":"2000","unstructured":"Petitclerc E, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, Sarras MP Jr, Hudson BG, Brooks PC (2000) New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 275:8051\u20138061","journal-title":"J Biol Chem"},{"key":"12_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0079-6603(08)60816-8","volume":"50","author":"T. Pihlajaniemi","year":"1995","unstructured":"Pihlajaniemi T, Rehn M (1995) Two new collagen subgroups: membrane-associated collagens and types XV and XVII. Prog Nucleic Acid Res Mol Biol 50:225\u2013262","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"12_CR83","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1242\/dev.01037","volume":"131","author":"E. Poschl","year":"2004","unstructured":"Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U (2004) Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131:1619\u20131628","journal-title":"Development"},{"key":"12_CR84","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1006\/bbrc.1999.0248","volume":"255","author":"R. Ramchandran","year":"1999","unstructured":"Ramchandran R, Dhanabal M, Volk R, Waterman MJ, Segal M, Lu H, Knebelmann B, Sukhatme VP (1999) Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 255:735\u2013739","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR85","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1073\/pnas.91.10.4234","volume":"91","author":"M. Rehn","year":"1994","unstructured":"Rehn M, Pihlajaniemi T (1994) Alpha l(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci USA 91:4234\u20134238","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR86","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1073\/pnas.031564998","volume":"98","author":"M. Rehn","year":"2001","unstructured":"Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Unionen M, Lombardo C, Pihlajaniemi T, Alitalo K, Vuori K (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 98:1024\u20131029","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR87","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0102-27","volume":"8","author":"L.E. Reynolds","year":"2002","unstructured":"Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8:27\u201334","journal-title":"Nat Med"},{"key":"12_CR88","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9440(10)65603-9","volume":"153","author":"J. Saarela","year":"1998","unstructured":"Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 153:611\u2013626","journal-title":"Am J Pathol"},{"key":"12_CR89","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1006\/jmbi.2000.3996","volume":"301","author":"T. Sasaki","year":"2000","unstructured":"Sasaki T, Larsson H, Tisi D, Claesson-Welsh L, Hohenester E, Timpl R (2000) Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol 301:1179\u20131190","journal-title":"J Mol Biol"},{"key":"12_CR90","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9440(10)65140-1","volume":"155","author":"M. Streit","year":"1999","unstructured":"Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, Lawler J, Detmar M (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155:441\u2013452","journal-title":"Am J Pathol"},{"key":"12_CR91","first-page":"2004","volume":"62","author":"M. Streit","year":"2002","unstructured":"Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange-Asschenfeldt B, Brown LF, Vacanti JP, Detmar M (2002) Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res 62:2004\u20132012","journal-title":"Cancer Res"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1073\/pnas.96.4.1246","volume":"96","author":"I. Struman","year":"1999","unstructured":"Struman I, Bentzien F, Lee H, Mainfroid V, D\u2019Angelo G, Goffin V, Weiner RI, Martial JA (1999) Opposing actions of intact and N-terminal fragments of the human prolactin\/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246\u20131251","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR93","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1073\/pnas.0730882100","volume":"100","author":"A. Sudhakar","year":"2003","unstructured":"Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 100:4766\u20134771","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1172\/JCI24813","volume":"115","author":"A. Sudhakar","year":"2005","unstructured":"Sudhakar A, Nyberg P, Keshamouni VG, Mannam AP, Li J, Sugimoto H, Cosgrove D, Kalluri R (2005) Human alphal type IV collagen NCI domain exhibits distinct antiangiogenic activity mediated by alphalbetal integrin. J Clin Invest 115:2801\u20132810","journal-title":"J Clin Invest"},{"key":"12_CR95","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-0463.2004.t01-1-apm11207-0806.x","volume":"112","author":"M. Sund","year":"2004","unstructured":"Sund M, Xie L, Kalluri R (2004) The contribution of vascular basement membranes and extracellular matrix to the mechanics of tumor angiogenesis. Apmis 112:450\u2013462","journal-title":"Apmis"},{"key":"12_CR96","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1073\/pnas.0500180102","volume":"102","author":"M. Sund","year":"2005","unstructured":"Sund M, Hamano Y, Sugimoto H, Sudhakar A, Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A, Kalluri R (2005) Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci USA 102:2934\u20132939","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR97","doi-asserted-by":"publisher","first-page":"39562","DOI":"10.1074\/jbc.M101815200","volume":"276","author":"T. Tarui","year":"2001","unstructured":"Tarui T, Miles LA, Takada Y (2001) Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem 276:39562\u201339568","journal-title":"J Biol Chem"},{"key":"12_CR98","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1432-1033.1981.tb05690.x","volume":"120","author":"R. Timpl","year":"1981","unstructured":"Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kuhn K (1981) A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 120:203\u2013211","journal-title":"Eur J Biochem"},{"key":"12_CR99","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrm1130","volume":"4","author":"R. Timpl","year":"2003","unstructured":"Timpl R, Sasaki T, Kostka G, Chu ML (2003) Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4:479\u2013489","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12_CR100","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1083\/jcb.152.6.1247","volume":"152","author":"B. Troyanovsky","year":"2001","unstructured":"Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L (2001) Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152:1247\u20131254","journal-title":"J Cell Biol"},{"key":"12_CR101","first-page":"6052","volume":"59","author":"W. Wen","year":"1999","unstructured":"Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J (1999) The generation of endostatin is mediated by elastase. Cancer Res 59:6052\u20136056","journal-title":"Cancer Res"},{"key":"12_CR102","first-page":"5580","volume":"62","author":"S.A. Wickstrom","year":"2002","unstructured":"Wickstrom SA, Alitalo K, Keski-Oja J (2002) Endostatin associates with integrin alpha5betal and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 62:5580\u20135589","journal-title":"Cancer Res"},{"key":"12_CR103","doi-asserted-by":"publisher","first-page":"20178","DOI":"10.1074\/jbc.M312921200","volume":"279","author":"S.A. Wickstrom","year":"2004","unstructured":"Wickstrom SA, Alitalo K, Keski-Oja J (2004) An endostatinderived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J Biol Chem 279:20178\u201320185","journal-title":"J Biol Chem"},{"key":"12_CR104","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1084\/jem.188.6.1039","volume":"188","author":"O.V. Volpert","year":"1998","unstructured":"Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP (1998) Inhibition of angiogenesis by interleukin 4. J Exp Med 188:1039\u20131046","journal-title":"J Exp Med"},{"key":"12_CR105","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nm0402-349","volume":"8","author":"O.V. Volpert","year":"2002","unstructured":"Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP (2002) Inducer-stimulated Fas targets activated endothelium for destruction by antiangiogenic thrombospondin-1 and pigment epitheliumderived factor. Nat Med 8:349\u2013357","journal-title":"Nat Med"},{"key":"12_CR106","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/emboj\/18.16.4414","volume":"18","author":"N. Yamaguchi","year":"1999","unstructured":"Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18:4414\u20134423","journal-title":"EMBO J"},{"key":"12_CR107","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V96.5.1900","volume":"96","author":"L. Yao","year":"2000","unstructured":"Yao L, Pike SE, Setsuda J, Parekh J, Gupta G, Raffeld M, Jaffe ES, Tosato G (2000) Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. Blood 96:1900\u20131905","journal-title":"Blood"},{"key":"12_CR108","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1073\/pnas.98.2.620","volume":"98","author":"M. Yi","year":"2001","unstructured":"Yi M, Ruoslahti E (2001) A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci USA 98:620\u2013624","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR109","doi-asserted-by":"publisher","first-page":"11435","DOI":"10.1073\/pnas.1635112100","volume":"100","author":"M. Yi","year":"2003","unstructured":"Yi M, Sakai T, Fassler R, Ruoslahti E (2003) Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc Natl Acad Sci USA 100:11435\u201311438","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR110","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00125-003-1276-4","volume":"47","author":"S.X. Zhang","year":"2004","unstructured":"Zhang SX, Sima J, Shao C, Fant J, Chen Y, Rohrer B, Gao G, Ma JX (2004) Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes. Diabetologia 47:124\u2013131","journal-title":"Diabetologia"}],"container-title":["Tumor Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-33177-3_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T03:24:43Z","timestamp":1684121083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-33177-3_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783540331766"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-33177-3_12","relation":{},"subject":[]}}